MG
PALI icon

Marex Group’s Palisade Bio PALI Stock Holding History

Marex Group’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,759
Closed -$24.3K – 860
2025
Q1 		$24.3K Hold
35,759
– – ﹤0.01% 659
2024
Q4 		$59K Hold
35,759
– – ﹤0.01% 634
2024
Q3 		$127K Hold
35,759
– – ﹤0.01% 523
2024
Q2 		$162K Buy
35,759
+33,375
+1,400% +$182K ﹤0.01% 530
2024
Q1 		$14.3K Hold
2,384
– – ﹤0.01% 462
2023
Q4 		$82.6K Buy
+2,384
New +$20.8K ﹤0.01% 506

Other funds holding PALI

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
T
Transce3nd Kyle, Texas $11.3M AUM 16.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Marex Group's PALI Position: Q2 2025 in Review

Marex Group sold out of Palisade Bio (PALI) in Q2 2025, closing a stake of 35,759 shares — an estimated $24.3K sold.

Marex Group first reported a position in PALI in Q4 2023 and held it in 6 quarters. The position peaked at $162K in Q2 2024. 11 funds tracked by Wall St. Rank hold PALI as of Q2 2025.

  • Marex Group reported no remaining Palisade Bio position as of Q2 2025 after selling out during the quarter.
  • Marex Group sold 35,759 Palisade Bio shares in Q2 2025, an estimated $24.3K.
  • Marex Group first reported a position in Palisade Bio in Q4 2023 and held it in 6 quarters.
  • Marex Group's Palisade Bio position peaked at $162K in Q2 2024.
  • 11 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2025.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.